ReviewActa pharmaceutica Sinica. B2022

Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy.

Yanyan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.